Prescription drug take back expansion
Definition of covered entity
In this section, the term “covered entity” means—
a State, local, or tribal law enforcement agency;
a manufacturer, distributor, or reverse distributor of prescription medications;
a retail pharmacy;
a registered narcotic treatment program;
a hospital or clinic with an onsite pharmacy;
an eligible long-term care facility; or
any other entity authorized by the Drug Enforcement Administration to dispose of prescription medications.
Program authorized
Notes
Editorial Notes
Codification
Statutory Notes and Related Subsidiaries
Guidance on At-Home Drug Disposal Systems
In General.—
Not later than one year after the date of enactment of this Act [
Contents.—
The guidance under subsection (a) shall include—
recommended standards for effective at-home drug disposal systems to meet applicable requirements enforced by the Food and Drug Administration;
recommended information to include as instructions for use to disseminate with at-home drug disposal systems;
best practices and educational tools to support the use of an at-home drug disposal system, as appropriate; and
recommended use of licensed health providers for the dissemination of education, instruction, and at-home drug disposal systems, as appropriate.”
Access to Increased Drug Disposal
SHORT TITLE.
DEFINITIONS.
“In this chapter—
the term ‘Attorney General’ means the Attorney General, acting through the Assistant Attorney General for the Office of Justice Programs;
the term ‘authorized collector’ means a narcotic treatment program, a hospital or clinic with an on-site pharmacy, a retail pharmacy, or a reverse distributor, that is authorized as a collector under section 1317.40 of title 21, Code of Federal Regulations (or any successor regulation);
the term ‘covered grant’ means a grant awarded under section 3003 [probably means section 3253; no section 3003 of Pub. L. 115–271 has been enacted]; and
the term ‘eligible collector’ means a person who is eligible to be an authorized collector.
AUTHORITY TO MAKE GRANTS.
APPLICATION.
“A State desiring a covered grant shall submit to the Attorney General an application that, at a minimum—
identifies the single State agency that oversees pharmaceutical care and will be responsible for complying with the requirements of the grant;
details a plan to increase participation rates of eligible collectors as authorized collectors; and
describes how the State will select eligible collectors to be served under the grant.
USE OF GRANT FUNDS.
ELIGIBILITY FOR GRANT.
DURATION OF GRANTS.
ACCOUNTABILITY AND OVERSIGHT.
“A State that receives a covered grant shall submit to the Attorney General a report, at such time and in such manner as the Attorney General may reasonably require, that—
lists the ultimate recipients of the grant amounts;
describes the activities undertaken by the State using the grant amounts; and
contains performance measures relating to the effectiveness of the grant, including changes in the participation rate of eligible collectors as authorized collectors.